Clinical Trial Update: Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily [Phase 4]

View source ↗

Summary

Phase 4 pilot trial evaluating once-daily monotherapy with lopinavir/ritonavir as a simplification regimen for HIV treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: Daniel Podzamczer | Conditions: HIV | Phase 4 | Status: COMPLETED